These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3147183)

  • 1. Copper distribution among serum proteins in paediatric liver disorders and malignancies.
    Barrow L; Tanner MS
    Eur J Clin Invest; 1988 Dec; 18(6):555-60. PubMed ID: 3147183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of calculated non-caeruloplasmin-bound copper in Wilson's disease.
    Duncan A; Yacoubian C; Beetham R; Catchpole A; Bullock D
    Ann Clin Biochem; 2017 Nov; 54(6):649-654. PubMed ID: 27742851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caeruloplasmin isoforms in Wilson's disease in neonates.
    Chowrimootoo GF; Scowcroft H; Seymour CA
    Arch Dis Child Fetal Neonatal Ed; 1998 Nov; 79(3):F198-201. PubMed ID: 10194991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced oxidase activity in the caeruloplasmin of two families with Wilson's disease.
    Gollan JL; Stocks J; Dormandy TL; Sherlock S
    J Clin Pathol; 1977 Jan; 30(1):81-3. PubMed ID: 838874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical identification of caeruloplasmin in hepatocytes of patients with Wilson's disease.
    Graul RS; Epstein O; Sherlock S; Scheuer PJ
    Liver; 1982 Sep; 2(3):207-11. PubMed ID: 6184593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective biliary copper excretion in Wilson's disease: the role of caeruloplasmin.
    Davis W; Chowrimootoo GF; Seymour CA
    Eur J Clin Invest; 1996 Oct; 26(10):893-901. PubMed ID: 8911863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct measurement of serum non-caeruloplasmin copper in liver disease.
    Frommer DJ
    Clin Chim Acta; 1976 May; 68(3):303-7. PubMed ID: 1277546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.
    Walshe JM;
    Ann Clin Biochem; 2003 Mar; 40(Pt 2):115-21. PubMed ID: 12662398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-caeruloplasmin copper and ferroxidase activity in mammalian serum. Ferroxidase activity and phenanthroline-detectable copper in human serum in Wilson's disease.
    Evans PJ; Bomford A; Halliwell B
    Free Radic Res Commun; 1989; 7(1):55-62. PubMed ID: 2806955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.
    Merle U; Schaefer M; Ferenci P; Stremmel W
    Gut; 2007 Jan; 56(1):115-20. PubMed ID: 16709660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.
    Chowrimootoo GF; Ahmed HA; Seymour CA
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):851-5. PubMed ID: 8645167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Wilson's disease caused by a controller gene mutation resulting in perpetuation of the fetal mode of copper metabolism into childhood?
    Epstein O; Sherlock S
    Lancet; 1981 Feb; 1(8215):303-5. PubMed ID: 6109943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical copper cirrhosis in Indian children.
    Ramakrishna B; Date A; Kirubakaran C; Raghupathy P
    Ann Trop Paediatr; 1995 Sep; 15(3):237-42. PubMed ID: 8534043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum antioxidant activity in normal and abnormal subjects.
    Cranfield LM; Gollan JL; White AG; Dormandy TL
    Ann Clin Biochem; 1979 Nov; 16(6):299-306. PubMed ID: 539789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment.
    Pfeiffenberger J; Lohse CM; Gotthardt D; Rupp C; Weiler M; Teufel U; Weiss KH; Gauss A
    J Inherit Metab Dis; 2019 Mar; 42(2):371-380. PubMed ID: 30746719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Western blot analysis in patients with hypocaeruloplasminaemia.
    Chowrimootoo GF; Andoh J; Seymour CA
    QJM; 1997 Mar; 90(3):197-202. PubMed ID: 9093597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper:caeruloplasmin ratio.
    Twomey PJ; Viljoen A; House IM; Reynolds TM; Wierzbicki AS
    J Clin Pathol; 2007 Apr; 60(4):441-2. PubMed ID: 17405985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the caeruloplasmin gene in the adult and neonatal rat liver.
    Barrow L; Tanner MS; Critchley DR
    Clin Sci (Lond); 1989 Sep; 77(3):259-63. PubMed ID: 2805592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathobiochemistry of Wilson's disease].
    Biesold D; Lössner J; Bachmann H; Zotter J
    Z Med Lab Diagn; 1982 Oct; 23(5):278-84. PubMed ID: 7180077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.